abstract |
The present invention relates to compounds of formula (I) in which A is optionally substituted heteroaryl. The compounds are useful in the treatment of diseases, such as metabolic disorders, mediated by acyl coA-diacylglycerol acyltransferase 1 (DGAT1). The invention also provides methods of treating such diseases and compounds and compositions useful in such treatments. |